Overview

Daily Chlorhexidine Care at the Exit Site in Peritoneal Dialysis Patients

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
0
Participant gender:
All
Summary
Chlorhexidine is used in central line dressing changes and is effective in reducing line infections. It is unclear if daily chlorhexidine care at the exit site in peritoneal dialysis (PD) patients can reduce the risk of Staphylococcus aureus (SA) colonization or exit site infection.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
E-DA Hospital
Treatments:
Chlorhexidine
Chlorhexidine gluconate
Criteria
Inclusion Criteria:

- patients > 20 years old who received PD for more than 3 months

Exclusion Criteria:

- a history of psychological illness or condition that interferes with caring of a wound

- recent (within 1 month) exit-site infection, peritonitis, or tunnel infection

- recent treatment with an antibiotic administered by any route in the last month

- or known hypersensitivity to or intolerance of chlorhexidine or mupirocin